Last edition
News about "generics and vaccines"
EY-OPPI Report Outlines Three-Pronged Strategy to Unlock India's USD 450 Billion Pharma Potential
India’s pharma industry will need to move from a volume-led approach to a model driven by value, innovation and stronger collaboration across the ecosystem if it is to achieve its projected value of USD 450 billion by 2047, says EY–OPPI Report.
Generics And Vaccines | 20/11/2025 | By Dineshwori | 208
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members